|
|
Volumn 18, Issue 4 Suppl 4, 2002, Pages 11-19
|
|
The epidermal growth factor receptor as a novel target for cancer therapy: case studies and clinical implications.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR;
ADENOCARCINOMA;
AGED;
CANCER STAGING;
CASE REPORT;
CLINICAL TRIAL;
DRUG ANTAGONISM;
FEMALE;
FOLLOW UP;
HUMAN;
LUNG TUMOR;
MALE;
METHODOLOGY;
MIDDLE AGED;
NEEDLE BIOPSY;
NURSE ATTITUDE;
NURSING;
ONCOLOGY NURSING;
REVIEW;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
SURVIVAL;
ADENOCARCINOMA;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIOPSY, NEEDLE;
CLINICAL TRIALS;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
NURSE'S ROLE;
ONCOLOGIC NURSING;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
SURVIVAL ANALYSIS;
|
|
EID: 0036878748
PISSN: 07492081
EISSN: None
Source Type: Journal
DOI: 10.1053/sonu.2002.37407 Document Type: Review |
|
Times cited : (5)
|
|
References (27)
|
